Efficacy and biomarker findings from AVaglio, a phase III trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma
Cloughesy, T, Mason, W, Henriksson, R, Saran, F, Nishikawa, R, Hilton, M, Garcia, J, Pallaud, C, Chinot, O
Published in Journal of the neurological sciences (15.10.2013)
Published in Journal of the neurological sciences (15.10.2013)
Get full text
Journal Article
9003 ORAL Biomarker Analysis in BO21015, a Phase II Randomised Study of First-line Bevacizumab (BEV) Combined With Carboplatin-gemcitabine (CG) or Carboplatin-paclitaxel (CP) in Patients (pts) With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer (NSCLC)
Mok, T, Gorbunova, V, Juhasz, E, Szima, B, Burdaeva, O, Yu, C.J, Delmar, P, Pallaud, C, Jonnaert, M, Reck, M
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Genetic influences on lipid metabolism trait variability within the Stanislas Cohort
Pallaud, C., Gueguen, R., Sass, C., Grow, M., Cheng, S., Siest, G., Visvikis, S.
Published in Journal of lipid research (01.11.2001)
Published in Journal of lipid research (01.11.2001)
Get full text
Journal Article
Candidate gene polymorphisms in cardiovascular disease : A comparative study of frequencies between a French and an Italian population
PALLAUD, Céline, STRANIERI, Chiara, SASS, Catherine, SIEST, Gérard, PIGNATTI, Franco, VISVIKIS, Sophie
Published in Clinical chemistry and laboratory medicine (01.02.2001)
Published in Clinical chemistry and laboratory medicine (01.02.2001)
Get full text
Journal Article
Sample size calculations for classical association and TDT-type methods using family data
TREGOUET, D. A., PALLAUD, C., SASS, C., VISVIKIS, S., TIRET, L.
Published in Annals of human genetics (01.05.2001)
Published in Annals of human genetics (01.05.2001)
Get full text
Journal Article
Sample size calculations for classical association and TDT‐type methods using family data
TREGOUET, D. A., PALLAUD, C., SASS, C., VISVIKIS, S., TIRET, L.
Published in Annals of human genetics (01.05.2001)
Published in Annals of human genetics (01.05.2001)
Get full text
Journal Article
Familial Studies on the Genetics of Cardiovascular Diseases: the Stanislas Cohort
Visvikis, Sophie, Sass, Catherine, Pallaud, Celine, Grow, Michael A., Zannad, Faiez, Siest, Gérard, Erlich, Henry A., Cheng, Suzanne
Published in Clinical chemistry and laboratory medicine (18.09.2000)
Published in Clinical chemistry and laboratory medicine (18.09.2000)
Get full text
Journal Article
Conference Proceeding
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival
Brück, Oscar, Dufva, Olli, Hohtari, Helena, Blom, Sami, Turkki, Riku, Ilander, Mette, Kovanen, Panu, Pallaud, Celine, Ramos, Pedro Marques, Lähteenmäki, Hanna, Välimäki, Katja, El Missiry, Mohamed, Ribeiro, Antonio, Kallioniemi, Olli, Porkka, Kimmo, Pellinen, Teijo, Mustjoki, Satu
Published in Blood advances (28.01.2020)
Published in Blood advances (28.01.2020)
Get full text
Journal Article
Multilocus approach to cardiovascular risk
Pallaud, C., Maurice, M., Cheng, S., Grow, M., Aguillon, D., Sass, C., Siest, G., Visvikis, S.
Published in Scandinavian journal of clinical and laboratory investigation (1999)
Published in Scandinavian journal of clinical and laboratory investigation (1999)
Get full text
Journal Article
1657P - Biomarker (BM) Results from the Phase III Averel Trial of 1st-Line Bevacizumab (BV), Trastuzumab (H) + Docetaxel (T) for HER2-Positive Locally Recurrent/Metastatic Breast Cancer (LR/MBC)
Gianni, L., Chan, A., Mansutti, M., Pivot, X., Greil, R., Provencher, L., Prot, S., Moore, N., Scherer, S.J., Pallaud, C.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Biomarker (BM) Results from the Phase III Averel Trial of 1st-Line Bevacizumab (BV), Trastuzumab (H) + Docetaxel (T) for HER2-Positive Locally Recurrent/Metastatic Breast Cancer (LR/MBC)
Gianni, L., Chan, A., Mansutti, M., Pivot, X., Greil, R., Provencher, L., Prot, S., Moore, N., Scherer, S.J., Pallaud, C.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Tumour Biomarker and Plasma Time Course Data from Abigail, A Phase II Study of 1st-Line Bevacizumab + Chemotherapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)
Reck, M., Gorbunova, V.A., Juhasz, E., Szima, B., Orlov, S., Yu, C., Pallaud, C., Scherer, S.J., Archer, V., Mok, T.S.K.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Clinical Genotyping and Efficacy Outcomes: Exploratory Biomarker Data from the Phase II Abigail Study of 1st-Line Bevacizumab + Chemotherapy in Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)
Pallaud, C., Reck, M., Juhasz, E., Szima, B., Yu, C., Burdaeva, O., Orlov, S., Scherer, S.J., Archer, V., Mok, T.S.K.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Abstract P3-06-34: Plasma (p) VEGF-A and VEGFR-2 biomarker (BM) results from the BEATRICE phase III trial of bevacizumab (BEV) in triple-negative early breast cancer (BC)
Carmeliet, P, Pallaud, C, Deurloo, RJ, Bubuteishvili-Pacaud, L, Henschel, V, Dent, R, Bell, R, Mackey, J, Scherer, SJ, Cameron, D
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Biomarker (BM) Results from GOG-0218, a Phase 3 Trial of Front-Line Bevacizumab (BV) + Chemotherapy (CT) for Ovarian Cancer (OC)
Birrer, M.J., Lankes, H., Burger, R.A., Mannel, R., Homesley, H., Henschel, V., Sovak, M., Scherer, S.J., de Haas, S., Pallaud, C.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
198P - Biomarker (BM) Results from GOG-0218, a Phase 3 Trial of Front-Line Bevacizumab (BV) + Chemotherapy (CT) for Ovarian Cancer (OC)
Birrer, M.J., Lankes, H., Burger, R.A., Mannel, R., Homesley, H., Henschel, V., Sovak, M., Scherer, S.J., de Haas, S., Pallaud, C.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
PS968 GENETIC LANDSCAPE OF FLT3‐MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS TREATED WITHIN THE RATIFY TRIAL: CALGB 10603 (ALLIANCE)
Jahn, N., Panina, E., Bullinger, L., Dolnik, A., Herzig, J., Blätte, T.J., Benner, A., Gambietz, A., Krzykalla, J., Gathmann, I., Larson, R.A., Lo‐Coco, F., Amadori, S., Prior, T.W., Brandwein, J.M., Appelbaum, F.R., Medeiros, B.C., Tallman, M.S., Tiecke, E., Pallaud, C., Ehninger, G., Heuser, M., Ganser, A., Stone, R.M., Thiede, C., Döhner, H., Bloomfield, C.D., Döhner, K.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
Cheng, S, Grow, M A, Pallaud, C, Klitz, W, Erlich, H A, Visvikis, S, Chen, J J, Pullinger, C R, Malloy, M J, Siest, G, Kane, J P
Published in Genome research (01.10.1999)
Published in Genome research (01.10.1999)
Get full text
Journal Article
PF260 PROGNOSTIC AND PREDICTIVE IMPACT OF NPM1/FLT3‐ITD GENOTYPES AS DEFINED BY 2017 EUROPEAN LEUKEMIANET RISK CATEGORIZATION FROM AML PATIENTS TREATED WITHIN THE INTERNATIONAL RATIFY STUDY
Döhner, K., Thiede, C., Jahn, N., Ekaterina, P., Gambietz, A., Prior, T.W., Marcucci, G., Jones, D., Krauter, J., Michael, H., Lo‐Coco, F., Ottone, T., Nomdedeu, J., Mandrekar, S.J., Huebner, L., Laumann, K.M., Geyer, S.M., Klisovic, R.B., Wei, A., Sierra, J., Sanz, M.A., Brandwein, J.M., Witte, T.M., Jansen, J.H., Niederwieser, D., Appelbaum, F.R., Medeiros, B.C., Tallman, M.S., Schlenk, R.F., Ganser, A., Serve, H., Ehninger, G., Amadori, S., Gathmann, I., Axel, B., Pallaud, C., Larson, R.A., Stone, R.M., Döhner, H., Bloomfield, C.D.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article